<table id="i7659017a-b069-464d-830b-bcb35cbbd201" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1 Oxaprozin Pharmacokinetic Parameters [Mean (%CV)](1200 mg)</caption>
<tbody>
<tr>
<td>
<br/>
</td>
<td>
<content stylecode="bold">Healthy Adults <br/>
</content>
</td>
<td>
<content stylecode="bold">(19 - 78 years)</content>
</td>
</tr>
<tr>
<td>
<br/>
</td>
<td>
<content stylecode="bold">Total Drug                     <br/>
</content>
</td>
<td>
<content stylecode="bold">Unbound Drug             <br/>
</content>
</td>
</tr>
<tr>
<td>
<br/>
</td>
<td>
<content stylecode="bold">Single             Multiple</content>
</td>
<td>
<content stylecode="bold">Single             Multiple</content>
</td>
</tr>
<tr>
<td>
<br/>
</td>
<td>
<content stylecode="bold">N=35                  N=12</content>
</td>
<td>
<content stylecode="bold">N=35                  N=12</content>
</td>
</tr>
<tr>
<td>T<sub>max</sub> (hr)<br/>
</td>
<td>3.09 (39)           2.44 (40)<br/>
</td>
<td>3.03 (48)           2.33 (35)<br/>
</td>
</tr>
<tr>
<td>Oral Clearance (L/hr/70 kg)<br/>
</td>
<td>
<br/>0.150 (24)        0.301 (29)<br/>
<br/>
</td>
<td>
<br/>136 (24)            102 (45)<br/>
<br/>
</td>
</tr>
<tr>
<td>Apparent Volume<br/>of  Distribution at Steady State (Vd/F; L/70 kg)                  <br/>
</td>
<td>
<br/>11.7 (13)           16.7 (14)<br/>
<br/>
<br/>
</td>
<td>
<br/>6230 (28)          2420 (38)<br/>
<br/>
<br/>
</td>
</tr>
<tr>
<td>Elimination Half-life (hr)<br/>
</td>
<td>54.9 (49)           41.4 (27)<br/>
</td>
<td>27.8 (34)           19.5 (15)<br/>
</td>
</tr>
</tbody>
</table>